The Procter & Gamble Company
NYSE:PGHousehold & Personal Products
+$0.53 today
- Market cap
- $394.70B
- Beta
- 0.39
- P/E (TTM)
- 21.9
- EPS (TTM)
- $6.90
- Dividend yield
- 2.82%
Volume 8.43M
Average 9.50M
PG Total Liabilities
Everything the company owes to creditors and other parties.
The Procter & Gamble CompanyNYSE: PG
Total Liabilities · Q1 FY2027 · quarter ended Sep 2026
Total liabilities rises 5.1% from a year ago
Total liabilities stood at $77.8B at the end of Q1 FY2027, up 5.1% from a year earlier and up 7.7% from the prior quarter. Over 3 fiscal years it compounded at -0.7% a year.
Context
- Total liabilities amounted to 58.4% of total assets at the end of Q1 FY2027, up 0.4 pp from a year earlier.
- Total liabilities increased in 1 of the last 3 fiscal years.
What to watch
Whether total liabilities keeps rising in the next quarterly balance sheet after a +5.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Liabilities history
USD · from the balance sheet
- Latest · FY2026
- 72.21B USD
- Year-over-year change
- -1.0%
- 4-year CAGR
- +0.7%
| Period | Period end | Total Liabilities | YoY change |
|---|---|---|---|
| FY2026 | 2026-06-30 | 72.21B | -1.0% |
| FY2025 | 2025-06-30 | 72.95B | +1.6% |
| FY2024 | 2024-06-30 | 71.81B | -2.6% |
| FY2023 | 2023-06-30 | 73.76B | +4.8% |
| FY2022 | 2022-06-30 | 70.35B | — |
Total Liabilities vs competitors
How PG compares with its peers on the latest reported figures
- Peers report in different currencies, so total liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +5.1% is the 3rd highest of 8, against a peer median of -0.6%.
- Total liabilities amounts to 58.4% of total assets for PG, versus a peer median of 79.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $77.8B USD | +5.1% | -0.7% | 58.4% | |
| Dec 2025 | €52.86B EUR | -7.6% | -2.0% | 75.0% | |
| Jun 2026 | $16.66B USD | +8.4% | -3.4% | 89.8% | |
| Sep 2026 | $16.51B USD | -0.6% | +30.5% | 61.9% | |
| Sep 2026 | $16.1B USD | -1.1% | +2.3% | 96.2% | |
| Sep 2026 | $15.93B USD | +3.1% | -2.1% | 79.8% | |
| Sep 2026 | $7.71B USD | +43.1% | +10.7% | 98.5% | |
| Sep 2026 | $4.85B USD | -1.4% | +0.4% | 52.0% | |
| Peer median (excluding PG) | — | -0.6% | +0.4% | 79.8% | |
Competitors are the stored peer set for PG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 | FY2026 Jun 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 7.21B | 8.25B | 9.48B | 9.56B | 9.94B |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 5.14B | 5.47B | 6.12B | 6.19B | 6.06B |
| Inventory | 6.92B | 7.07B | 7.02B | 7.55B | 8.17B |
| Other Current Assets | 2.37B | 1.86B | 2.09B | 2.1B | 2.04B |
| Total Current Assets | 21.65B | 22.65B | 24.71B | 25.39B | 26.21B |
| Property, Plant & Equipment (Net) | 21.2B | 21.91B | 22.15B | 23.9B | 25.36B |
| Goodwill | 39.7B | 40.66B | 40.3B | 41.65B | 41.28B |
| Intangible Assets | 23.68B | 23.78B | 22.05B | 21.91B | 21.44B |
| Long-term Investments | 140M | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 10.84B | 11.83B | 13.16B | 12.38B | 12.23B |
| Total Non-current Assets | 95.56B | 98.18B | 97.66B | 99.84B | 100.31B |
| Total Assets | 117.21B | 120.83B | 122.37B | 125.23B | 126.52B |
| Account Payables | 14.88B | 14.6B | 15.36B | 15.23B | 16.31B |
| Short-term Debt | 8.65B | 10.23B | 7.19B | 9.51B | 11.3B |
| Tax Payables | 587M | 828M | 1.04B | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.88B | 5.75B | 5.33B | 5.74B | 5.63B |
| Total Current Liabilities | 33.08B | 35.76B | 33.63B | 36.06B | 38.69B |
| Long-term Debt | 22.85B | 24.38B | 25.27B | 25B | 22.84B |
| Deferred Tax Liabilities | 6.81B | 6.48B | 6.52B | 5.77B | 5.76B |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 7.02B | 6.56B | 5.73B | 5.42B | 4.27B |
| Total Non-current Liabilities | 37.27B | 38.01B | 38.19B | 36.89B | 33.52B |
| Total Liabilities | 70.35B | 73.76B | 71.81B | 72.95B | 72.21B |
| Common Stock | 4.01B | 4.01B | 4.01B | 4.01B | 4.01B |
| Retained Earnings | 112.43B | 118.17B | 123.81B | 129.97B | 135.85B |
| Accumulated OCI | (12.19B) | (12.22B) | (11.9B) | (12.14B) | (12.47B) |
| Other Stockholders Equity | (916M) | (821M) | (737M) | (672M) | 390M |
| Minority Interest | 265M | 288M | 272M | 272M | 230M |
| Total Equity | 46.85B | 47.07B | 50.56B | 52.28B | 54.54B |
| Total Debt | 32.29B | 35.42B | 33.37B | 35.46B | 35.03B |
| Net Debt | 25.08B | 27.18B | 23.89B | 25.91B | 25.08B |
The Procter & Gamble Company
NYSE:PG
Intrinsic Alpha fair value
Locked
Current Price
$170.29
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.